Alnylam Pharmace. sell fchar99
Start price
26.09.17
/
50%
€100.57
Target price
26.03.18
€73.96
Performance (%)
24.00%
End price
26.03.18
€124.70
Summary
This prediction ended on 26.03.18 with a price of €124.70. The prediction closed with a disappointing performance of 24.00%. fchar99 has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 3.192% | 3.192% | -49.479% | 14.628% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by fchar99 for this prediction
In the thread Alnylam Pharmace. diskutieren
Schau auf negative Zahlen!
Blick auf Beschreibung und Finanzen! LOTS von - #S (NEGATIVE) -----! Ich bin großzügig mit mu Preis!
(Laufzeit überschritten)